Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000401:mortality; D004311:Double-Blind Method; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D019782:Riluzole; D016019:Survival Analysis; D013844:Thiazoles / Q000627:therapeutic use*; D014139:Tracheostomy
D018696:Neuroprotective Agents; D013844:Thiazoles; D019782:Riluzole